OPSYNVI

Serial Number 90165717
Registration 7257052
700

Registration Progress

Application Filed
Sep 8, 2020
Under Examination
Apr 20, 2021
Approved for Publication
Feb 23, 2021
Published for Opposition
Oct 17, 2023
Registered
Jan 2, 2024

Trademark Image

OPSYNVI

Basic Information

Serial Number
90165717
Registration Number
7257052
Filing Date
September 8, 2020
Registration Date
January 2, 2024
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 2, 2024
Registration
Registered
Classes
005

Rights Holder

Actelion Pharmaceuticals Ltd

99
Address
Gewerbestrasse 16
Allschwil CH-4123
CH

Ownership History

Actelion Pharmaceuticals Ltd

Original Applicant
99
Allschwil CH

Actelion Pharmaceuticals Ltd

Owner at Publication
99
Allschwil CH

Actelion Pharmaceuticals Ltd

Original Registrant
99
Allschwil CH

Legal Representation

Attorney
Cheryl Foytlin

USPTO Deadlines

Next Deadline
1610 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-02)
Due Date
January 02, 2030
Grace Period Ends
July 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Jan 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 14, 2023 APET A ASSIGNED TO PETITION STAFF Loading...
Sep 14, 2023 PCBG O PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Loading...
Sep 14, 2023 ADBS I 1(B) BASIS DELETED; NEW BASIS REQUESTED Loading...
Sep 14, 2023 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Aug 23, 2023 TPAD I TEAS PETITION TO AMEND BASIS RECEIVED Loading...
Aug 23, 2023 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Feb 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 14, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 19, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 19, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 7, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 7, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 8, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 6, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 6, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 6, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 20, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 23, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 23, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 3, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 14, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 14, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 14, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 11, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives

Classification

International Classes
005